BIO · Bio-Rad Laboratories, Inc. · Fails to Deliver
$372.18
-12.22 (-3.18%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$9.95B
Shares
26.74M
Volume · Oct 30
183.13K
Avg daily vol (3M)
254.36K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-22 | 451 | $377.33 | $170,176 |
| 2026-09-14 | 400 | $369.32 | $147,728 |
| 2026-09-10 | 2,061 | $376.97 | $776,935 |
| 2026-09-08 | 3 | $386.11 | $1,158 |
| 2026-09-03 | 4,193 | $388.51 | $1,629,022 |
| 2026-08-25 | 17,170 | $381.76 | $6,554,819 |
| 2026-08-18 | 13,658 | $355.23 | $4,851,731 |
| 2026-08-11 | 102 | $354.54 | $36,163 |
| 2026-08-05 | 6,024 | $332.88 | $2,005,269 |
Showing 1–9 of 9 settlements
Key facts
CIK
12208
CUSIP
090572207
13F (30d)
147 filings
120 filers
Visit website
Investor relations